Similar articles

• Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer.

  Reck M, von Pawel J, Macha HN, Kaukel E, Deppermann KM, Bonnet R, Ulm K, Hessler S, Gatzemeier U. Reck M, et al. J Natl Cancer Inst. 2003 Aug 6;95(15):1118-27. doi: 10.1093/jnci/djg017. J Natl Cancer Inst. 2003. PMID: 12902441 Clinical Trial.
• Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.

  Reck M, von Pawel J, Macha HN, Kaukel E, Deppermann KM, Bonnet R, Ulm K, Hessler S, Gatzemeier U. Reck M, et al. Lung Cancer. 2006 Jul;53(1):67-75. doi: 10.1016/j.lungcan.2006.04.001. Epub 2006 May 19. Lung Cancer. 2006. PMID: 16713013 Clinical Trial.
• Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.

  Hainsworth JD, Gray JR, Stroup SL, Kalman LA, Patten JE, Hopkins LG, Thomas M, Greco FA. Hainsworth JD, et al. J Clin Oncol. 1997 Dec;15(12):3464-70. doi: 10.1200/JCO.1997.15.12.3464. J Clin Oncol. 1997. PMID: 9396399 Clinical Trial.
• Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer.

  Lorigan P, Lee SM, Betticher D, Woodhead M, Weir D, Hanley S, Hardy C, Thatcher N. Lorigan P, et al. Semin Oncol. 1995 Jun;22(3 Suppl 7):32-41. Semin Oncol. 1995. PMID: 7610397 Review.
• The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.

  Ettinger DS. Ettinger DS. Semin Oncol. 1995 Feb;22(1 Suppl 2):23-7. Semin Oncol. 1995. PMID: 7846538 Review.